Treating elderly patients with breast cancer

作者: R. Jones , R. C. F. Leonard

DOI: 10.1017/S1470903105002324

关键词:

摘要:

参考文章(27)
Early Breast Cancer Trialists' Collaborative Group, None, Polychemotherapy for early breast cancer: an overview of the randomised trials The Lancet. ,vol. 352, pp. 930- 942 ,(1998) , 10.1016/S0140-6736(98)03301-7
Henning Mouridsen, Mikhail Gershanovich, Yan Sun, Ramón Pérez-Carrión, Corrado Boni, Alain Monnier, Justus Apffelstaedt, Robert Smith, Harm P. Sleeboom, Fritz Jänicke, Anna Pluzanska, Magdolna Dank, Dominique Becquart, Poonamalle P. Bapsy, Eeva Salminen, Ray Snyder, Mercedes Lassus, J. Arnold Verbeek, Beatrix Staffler, Hilary A. Chaudri-Ross, Margaret Dugan, Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group Journal of Clinical Oncology. ,vol. 19, pp. 2596- 2606 ,(2001) , 10.1200/JCO.2001.19.10.2596
M. Margaret Kemeny, Bercedis L. Peterson, Alice B. Kornblith, Hyman B. Muss, Judith Wheeler, Ellis Levine, Nancy Bartlett, Gini Fleming, Harvey J. Cohen, Barriers to Clinical Trial Participation by Older Women With Breast Cancer Journal of Clinical Oncology. ,vol. 21, pp. 2268- 2275 ,(2003) , 10.1200/JCO.2003.09.124
Brian N. Stein, Nicholas J. Petrelli, Harold O. Douglass, Deborah L. Driscoll, Giuseppina Arcangeli, Neal J. Meropol, Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial Cancer. ,vol. 75, pp. 11- 17 ,(1995) , 10.1002/1097-0142(19950101)75:1<11::AID-CNCR2820750104>3.0.CO;2-N
M Vercelli, A Quaglia, C Casella, S Parodi, R Capocaccia, C Martinez Garcia, EUROCARE Working Group, Relative survival in elderly cancer patients in Europe European Journal of Cancer. ,vol. 34, pp. 2264- 2270 ,(1998) , 10.1016/S0959-8049(98)00325-6
D Crivellari, S Spazzapan, D Lombardi, M Berretta, MD Magri, R Sorio, S Scalone, A Veronesi, Treatment of older breast cancer patients with high recurrence risk Critical Reviews in Oncology Hematology. ,vol. 46, pp. 241- 246 ,(2003) , 10.1016/S1040-8428(03)00023-4